HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics.

Journal of Molecular Biology
Stephanie Tristram-NagleJohn F Nagle

Abstract

This work investigates the interaction of N-terminal gp41 fusion peptide (FP) of human immunodeficiency virus type 1 (HIV-1) with model membranes in order to elucidate how FP leads to fusion of HIV and T-cell membranes. FP constructs were (i) wild-type FP23 (23 N-terminal amino acids of gp41), (ii) water-soluble monomeric FP that adds six lysines on the C-terminus of FP23 (FPwsm), and (iii) the C-terminus covalently linked trimeric version (FPtri) of FPwsm. Model membranes were (i) LM3 (a T-cell mimic), (ii) 1,2-dioleoyl-sn-glycero-3-phosphocholine, (iii) 1,2-dioleoyl-sn-glycero-3-phosphocholine/30 mol% cholesterol, (iv) 1,2-dierucoyl-sn-glycero-3-phosphocholine, and (v) 1,2-dierucoyl-sn-glycero-3-phosphocholine/30 mol% cholesterol. Diffuse synchrotron low-angle x-ray scattering from fully hydrated samples, supplemented by volumetric data, showed that FP23 and FPtri penetrate into the hydrocarbon region and cause membranes to thin. Depth of penetration appears to depend upon a complex combination of factors including bilayer thickness, presence of cholesterol, and electrostatics. X-ray data showed an increase in curvature in hexagonal phase 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, which further indicates that FP23 penetra...Continue Reading

References

Apr 21, 1975·Biochimica Et Biophysica Acta·J N Israelachvili, D J Mitchell
Jan 11, 1992·Proceedings of the National Academy of Sciences of the United States of America·E O FreedA T Panganiban
Jul 14, 1987·Biochemistry·S Tristram-NagleJ F Nagle
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R C AloiaF C Jensen
Jan 1, 1996·Annual Review of Cell and Developmental Biology·L D HernandezJ M White
May 22, 1997·Nature·W WeissenhornD C Wiley
Aug 26, 1998·The EMBO Journal·M CaffreyG M Clore
May 20, 1999·Molecular Membrane Biology·W WeissenhornD C Wiley
Jun 8, 1999·Annual Review of Immunology·E A BergerJ M Farber
Jul 2, 1999·Journal of Structural Biology·Z N YangC C Hyde
Nov 7, 2000·Biochimica Et Biophysica Acta·J F Nagle, S Tristram-Nagle
Mar 10, 2001·Biopolymers·R M Epand, R F Epand
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Jun 11, 2002·Biochemical and Biophysical Research Communications·Victoria Dominguez Del AngelIsabelle Callebaut
Jan 9, 2003·Chemical Reviews·Robert BlumenthalRichard M Epand
Feb 26, 2003·Cell·Reinhard JahnThomas C Südhof
Jun 1, 2004·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·Yufeng Liu, John F Nagle
Oct 12, 2004·Biophysical Journal·Loredana VaccaroFranca Fraternali
Jan 31, 2006·Biophysical Journal·Jeffery B KlaudaJohn F Nagle

❮ Previous
Next ❯

Citations

Sep 17, 2013·International Journal of Molecular Sciences·Stefania GaldieroMassimiliano Galdiero
Apr 8, 2014·Chemistry and Physics of Lipids·Beatriz ApellánizJosé L Nieva
Mar 15, 2016·Biochimica Et Biophysica Acta·A WestJ N Sachs
Oct 20, 2012·The Journal of General Virology·Jonathan D SteckbeckRonald C Montelaro
May 28, 2013·Biophysical Journal·Alexander J Sodt, Richard W Pastor
Jul 3, 2013·Biochimica Et Biophysica Acta·Irina D PogozhevaAndrei L Lomize
Jan 27, 2015·Biochimica Et Biophysica Acta·Beatriz Apellániz, José L Nieva
Jul 15, 2015·Biophysical Journal·Mariya ChavarhaStephen B Hall
Jan 30, 2014·Biochimica Et Biophysica Acta·Yury S TarahovskyEugeny N Muzafarov
Mar 29, 2014·Advances in Colloid and Interface Science·Rumiana Dimova
Jan 15, 2014·Biophysical Journal·Alex L Lai, Jack H Freed
Nov 9, 2011·Biochimica Et Biophysica Acta·Libo B LiToby W Allen
Aug 3, 2012·Biophysical Journal·P WadhwaniR M Epand
Jun 29, 2013·Faraday Discussions·John F Nagle
Jul 19, 2016·Biochimica Et Biophysica Acta·A AgopianS Castano
Nov 5, 2016·Biochimica Et Biophysica Acta·Lauren O'NeilStephanie Tristram-Nagle
Jan 21, 2017·Chemistry and Physics of Lipids·William T Heller, Durgesh K Rai
Sep 1, 2018·Small·Chia-Wei LeeIng-Shouh Hwang
Aug 16, 2014·The Journal of Biological Chemistry·Mikaela D StewartTatyana I Igumenova
Feb 23, 2019·Soft Matter·Elizabeth G KelleyMichihiro Nagao
May 19, 2018·International Journal of Molecular Sciences·Rodion J MolotkovskySergey A Akimov
Dec 22, 2020·Structural Dynamics·Michihiro NagaoChristopher L Kitchens
Sep 26, 2012·Physical Review Letters·Andrey IvankinDavid Gidalevitz
Feb 25, 2021·Biophysical Chemistry·Thaís F SchmidtChristian Salesse
May 26, 2020·Biochimica Et Biophysica Acta. Biomembranes·Morgan RobinsonZoya Leonenko
Dec 11, 2020·Chemistry and Physics of Lipids·Geetanjali Meher, Hirak Chakraborty
May 5, 2021·Soft Matter·Elizabeth G KelleyMichihiro Nagao
May 20, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bingen G MonasterioAlicia Alonso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.